Detection of Reduced Left Ventricular Ejection Fraction With Three-Lead ECG Using Artificial Intelligence

ConditionLow Ejection Fraction

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorEko Devices, Inc.

About this trial

The main objectives of this study are to train and evaluate an algorithm that predicts whether an individual has an ejection fraction ≤ 40%, using heart sounds and a 3-lead ECG as inputs, as well as determine the impact of gender, age, and race on algorithm performance.

Eligibility criteria

Qualifiers

Adults aged 18 years and older

Able and willing to provide informed consent

Complete a clinical echocardiogram within 7 days before or after study procedures

Disqualifiers

Unwilling or unable to provide informed consent

Patients who are hospitalized

Trial design

Treatments tested in this trial

Eko digital stethoscopes

Treatment groups

No treatment groups listed

Sponsors and collaborators

Eko Devices, Inc.

Lead sponsor

Source ClinicalTrials.gov